We are live on ! Find out more
MSA

Marino Stram & Associates Portfolio holdings

AUM $628M
1-Year Est. Return 23.07%
This Fund
S&P 500
This Quarter Est. Return
+5.07%
1 Year Est. Return
+23.07%
3 Year Est. Return
+63.64%
5 Year Est. Return
+76.05%
10 Year Est. Return
–
AUM
$353M
AUM Growth
+$22.1M
Cap. Flow
+$7.27M
Cap. Flow %
2.06%
Top 10 Hldgs %
58.47%
Holding
164
New
9
Increased
83
Reduced
52
Closed
2

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$1.57M
2
VYM icon
Vanguard High Dividend Yield ETF
VYM
+$1.1M
3
IVV icon
iShares Core S&P 500 ETF
IVV
+$967K
4
DGRO icon
iShares Core Dividend Growth ETF
DGRO
+$585K
5
SDY icon
State Street SPDR S&P Dividend ETF
SDY
+$536K

Top Sells

Rank Stock Value
1
DKNG icon
DraftKings
DKNG
+$1.92M
2
TRV icon
Travelers Companies
TRV
+$254K
3
TBIL
F/m US Treasury 3 Month Bill Fund
TBIL
+$239K
4
VZ icon
Verizon
VZ
+$125K
5
MPC icon
Marathon Petroleum
MPC
+$83.1K

Sector Composition

Rank Sector Weight
1 Technology 6.45%
2 Healthcare 5.86%
3 Consumer Discretionary 4.65%
4 Consumer Staples 4.57%
5 Financials 4.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UL icon
101
Unilever
UL
$136B
$501K 0.14%
8,540
-337
-4% -$20K
HD icon
102
Home Depot
HD
$355B
$490K 0.14%
1,578
+2
+0.1% +$591
CVX icon
103
Chevron
CVX
$366B
$488K 0.14%
3,104
+14
+0.5% +$2.25K
CL icon
104
Colgate-Palmolive
CL
$74.4B
$485K 0.14%
6,299
+181
+3% +$14K
T icon
105
AT&T
T
$163B
$478K 0.14%
29,825
+4,385
+17% +$74.7K
NVS icon
106
Novartis
NVS
$297B
$468K 0.13%
4,639
+2
+0% +$200
CVS icon
107
CVS Health
CVS
$122B
$427K 0.12%
6,172
-237
-4% -$16.9K
ADI icon
108
Analog Devices
ADI
$190B
$414K 0.12%
2,123
+1,082
+104% +$200K
AXP icon
109
American Express
AXP
$230B
$407K 0.12%
2,335
+48
+2% +$7.75K
AVGO icon
110
Broadcom
AVGO
$2.04T
$399K 0.11%
4,600
+70
+2% +$4.99K
PPL
111
PPL Corp
PPL
$26.7B
$393K 0.11%
14,844
-1,622
-10% -$44.7K
INTC icon
112
Intel
INTC
$513B
$387K 0.11%
11,558
-683
-6% -$21.4K
IWD icon
113
iShares Russell 1000 Value ETF
IWD
$83.7B
$377K 0.11%
2,386
+210
+10% +$32.1K
RTX icon
114
RTX Corp
RTX
$301B
$376K 0.11%
3,837
– –
MDT icon
115
Medtronic
MDT
$112B
$364K 0.1%
4,136
+171
+4% +$14.7K
BA icon
116
Boeing
BA
$185B
$362K 0.1%
1,714
-41
-2% -$8.52K
NVDA icon
117
NVIDIA
NVDA
$5.42T
$355K 0.1%
8,400
-30
-0.4% -$996
TSLA icon
118
Tesla
TSLA
$1.3T
$353K 0.1%
1,348
+285
+27% +$57K
BMY icon
119
Bristol-Myers Squibb
BMY
$132B
$348K 0.1%
5,448
+4
+0.1% +$268
QCOM icon
120
Qualcomm
QCOM
$176B
$347K 0.1%
2,912
-7
-0.2% -$805
TROW icon
121
T. Rowe Price
TROW
$24.3B
$341K 0.1%
3,046
+1
+0% +$109
VNQ icon
122
Vanguard Real Estate ETF
VNQ
$39B
$336K 0.1%
4,024
– –
UNH icon
123
UnitedHealth
UNH
$370B
$335K 0.09%
697
+13
+2% +$6.36K
ADBE icon
124
Adobe
ADBE
$105B
$329K 0.09%
673
– –
MMM icon
125
3M
MMM
$94.3B
$325K 0.09%
3,882
-351
-8% -$29.8K
3 4
5
6 7

Similar funds

TTSTC
Texas Treasury Safekeeping Trust Company Austin, Texas $628M AUM 15.58% 1-Year Est. Return
PWW
Pettyjohn Wood & White Lynchburg, Virginia $628M AUM 20.96% 1-Year Est. Return
FCFC
First Commonwealth Financial Corp Indiana, Pennsylvania $629M AUM 20.47% 1-Year Est. Return
MWP
Madison Wealth Partners Madison, Wisconsin $627M AUM 17.95% 1-Year Est. Return
VIM
Vancity Investment Management Vancouver, British Columbia, Canada $629M AUM 2.49% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
KCMH
Keywise Capital Management (HK) Hong Kong $630M AUM 81.01% 1-Year Est. Return
SGA
Strategic Global Advisors Newport Beach, California $625M AUM 28.76% 1-Year Est. Return

Marino Stram & Associates's Q2 2023 Portfolio in Review

As of Q2 2023, Marino Stram & Associates held 164 positions worth $353M, up 6.7% from $331M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Marino Stram & Associates's Q2 2023 filing shows 9 new, 83 increased, 52 reduced and 2 closed positions. Its largest new stake was Akamai: 5,880 shares worth $528K. The largest sale was DraftKings, an estimated $1.92M.

By sector, the portfolio is most concentrated in Technology at 6.5% of assets, up from 5.6% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Marino Stram & Associates's largest Q2 2023 buy was Akamai: 5,880 shares worth $528K.
  • Marino Stram & Associates added most to Johnson & Johnson in Q2 2023, an estimated $1.57M increase.
  • Marino Stram & Associates's biggest Q2 2023 reduction was DraftKings, cutting an estimated $1.92M.
  • Marino Stram & Associates fully exited Travelers Companies in Q2 2023, selling an estimated $254K.
  • Marino Stram & Associates's ten largest holdings make up 58% of its $353M portfolio in Q2 2023.
  • Marino Stram & Associates opened 9 new positions and closed 2 in Q2 2023.
  • Marino Stram & Associates's portfolio value rose 6.7% quarter-over-quarter to $353M.

Based on Marino Stram & Associates's 13F filing for Q2 2023, filed 20 Jul 2023.